You will hear plenty of commentary from Fitbit (FIT) fans and investors regarding the future of Fitbit with a focus on the company evolving or spiriting products for the healthcare industry. Of course, this is exactly what Fitbit desires from investor sentiment as the company witnesses its sales in the consumer industry nearing saturation in many regions around the world….
Good weekend Finom Group members! This weekend is our “off reporting” weekend, but as always, we desire to offer...
The mid-cycle transition de-rating is advanced but unfinished. Falling earnings revision breadth this fall will likely complete that process....
Absolute best investors I’ve encountered aren’t successful because they predicted the trend or the macro-outlook, but because they have...
Last week, the Q2 2018 reporting cycle kicked-off with some of the big banks reporting quarterly results. JP Morgan...
In 2015, I penned my first article on the subject matter surrounding VIX-leveraged ETF/ETNs. Back then, as if it...
There isn’t much ‘feeling’ on the part of bulls or bears these days. As discussed previously, with seven months...
What can you say about Fitbit’s (FIT) executive team other than “Wow”? After lowering FY16 guidance upon missing Q3...
For this week’s tech report, we focus on that shiny precious metal: gold. Ever since the post-recession high in...
JPM Market Recap
$0.00
JPM Research Note
$0.00
JP Morgan Market Volatility Report
$0.00
MarketWatch.com – Top Stories
